Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.66% | -13.59% | 433.92% | 37.18% | 27.00% |
| Total Depreciation and Amortization | 1.10% | 2.84% | -4.29% | 2.38% | -0.53% |
| Total Amortization of Deferred Charges | -- | -- | 31.05% | -- | -- |
| Total Other Non-Cash Items | 86.52% | 799.38% | 13.06% | 115.83% | 58.93% |
| Change in Net Operating Assets | 8.04% | -3.39% | -23.13% | -82.39% | 161.64% |
| Cash from Operations | 13.77% | 54.93% | 31.53% | -19.92% | 84.69% |
| Capital Expenditure | -59.58% | -44.98% | -91.93% | -23.62% | -2.11% |
| Sale of Property, Plant, and Equipment | -34.42% | -1.30% | -27.38% | 107.52% | 31.66% |
| Cash Acquisitions | 78.77% | 16.77% | -79.90% | 73.53% | -46.77% |
| Divestitures | -164.90% | -90.99% | -67.02% | 13,946.28% | -99.75% |
| Other Investing Activities | -366.19% | 7.39% | -43.51% | 93.16% | -36.69% |
| Cash from Investing | -95.33% | -74.08% | -283.18% | 73.89% | -146.44% |
| Total Debt Issued | -59.42% | 62.82% | 752.32% | 1,269.44% | 1,482.15% |
| Total Debt Repaid | -7.06% | -2.17% | 72.14% | -71.53% | -44.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.94% | -- | -- | -- | -27.60% |
| Other Financing Activities | -71.02% | -21.20% | 52.91% | -332.94% | -81.25% |
| Cash from Financing | -1,095.45% | -249.34% | 76.42% | -153.05% | 109.98% |
| Foreign Exchange rate Adjustments | 103.05% | 192.73% | -169.18% | -39.51% | -864.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.42% | -275.30% | 285.48% | -279.18% | 944.23% |